Skip to main content

Table 2 Clinical outcomes between study groups

From: Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis

 

Non HES group (n=72)

HES group (n=57)

Odds ratio (95%CI)

p value

Primary outcome

10 (13.8%)

19 (33.3%)

3.1 (1.30-7.36)

0.01

Rebleeding

4 (5.6%)

0 (0%)

0.54 (0.46-0.64)

0.13

HCP requiring CSF shunting

3 (4.2%)

12 (21%)

6.1 (1.63-22.95)

0.004

Delayed cerebral ischemia

5 (6.9%)

10 (17.5%)

2.86 (0.91-8.88)

0.09

  1. Data reported as count (%).
  2. HCP Hydrocephalous.
  3. CSF Cerebrospinal fluid.
  4. CI Confidence interval.